DB
EW icon

Danske Bank’s Edwards Lifesciences EW Stock Holding History

Danske Bank’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.4M Sell
524,490
-10,234
-2% -$857K 0.09% 173
2026
Q1 		$42.8M Buy
534,724
+188,201
+54% +$15.5M 0.1% 166
2025
Q4 		$29.5M Buy
346,523
+32,200
+10% +$2.64M 0.07% 234
2025
Q3 		$24.4M Buy
314,323
+10,010
+3% +$782K 0.06% 264
2025
Q2 		$23.8M Buy
304,313
+27,400
+10% +$2.04M 0.06% 258
2025
Q1 		$20.1M Sell
276,913
-50,375
-15% -$3.61M 0.06% 267
2024
Q4 		$24.2M Buy
327,288
+45,075
+16% +$3.15M 0.07% 240
2024
Q3 		$18.6M Sell
282,213
-135,834
-32% -$9.87M 0.06% 262
2024
Q2 		$38.6M Buy
418,047
+122,639
+42% +$10.9M 0.14% 129
2024
Q1 		$28.2M Buy
+295,408
New +$24.8M 0.09% 199

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Danske Bank's EW Position: Q2 2026 in Review

Danske Bank reduced its Edwards Lifesciences (EW) stake by 1.9% in Q2 2026, selling an estimated $857K and leaving 524,490 shares worth $47.4M. The position accounts for 0.09% of the portfolio, ranked #173.

Danske Bank first reported a position in EW in Q1 2024 and has held it in 10 quarters since. 1,212 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Danske Bank held 524,490 shares of Edwards Lifesciences worth $47.4M as of Q2 2026.
  • Danske Bank sold 10,234 Edwards Lifesciences shares in Q2 2026, an estimated $857K.
  • Edwards Lifesciences made up 0.09% of Danske Bank's portfolio in Q2 2026, its #173 holding.
  • Danske Bank first reported a position in Edwards Lifesciences in Q1 2024 and has held it in 10 quarters since.
  • 1,212 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.